The Wistar Institute’s vaccine center study shows its Zika vaccine protects from infection, brain damage, and death.
Trials of a new Zika vaccine have been 100 percent successful in blocking the virus and its devastating side effects, a report reveals.
The global spread of the disease shows no sign of letting up, and efforts to control it have so far proved futile.
However, the first clinical trial to test Zika-susceptible animals has found that a synthetic DNA vaccine successfully protected the immune system and brain of lab rats in every case.
It is the most promising result of a Zika vaccine to date – and it is the same one being tested in the first human clinical trials.
None of the lab rats in the study in Philadelphia’s Wistar Institute contracted Zika after getting the vaccine.
Those that were infected before being vaccinated were protected from any kind of damage to the brain’s hippocampus and cerebral cortex – Zika’s targets.
‘Our results support the critical importance of immune responses for both preventing infection as well as ameliorating disease caused by the Zika virus,’ said lead researcher Dr David Weiner, director of The Wistar Institute’s vaccine center. DailyMail